Downstaging of Thyroid Cancer Does Not Necessarily Imply Lower Mortality
Thyroid World Congress ePoster Library. Teliti M. 06/21/19; 272058; 163
Dr. Marsida Teliti
Dr. Marsida Teliti
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Abstract
Rate & Comment (0)

Background According to the new 8th AJCC/TNM edition, we investigated the effect of downstaging in patients with thyroid cancer (TC).

Methods From a large cohort of patients actively followed-up for TC since 2002, we retrospectively reviewed 46 with disease-specific mortality (17 males, 29 females and mean age 67±13,96yrs). 

Results Histologically, TCs were: papillary (PTC) in 16 cases (35%), follicular in 8 (17%), both PTC and Hurthle cancer in 1 (2%), poorly differentiated (PD) in 6 (13%), anaplastic in 5 (11%) and medullary in 6 (13%). No histological diagnosis was available in 4. On diagnosis, 10 patients were aged <55yrs. In patients with PD TC and well-differentiated (WD) TC, disease-specific deaths occurred in 19. TNM stages were downgraded in 11 of these (58%): 6 patients from stage III to II; 3 patients from stage IV to III; and 2 patients from stage IV to II. Their mean age was 64yrs; 4 were aged <55yrs. Ten patients underwent radioactive iodine ablation (RAI) with a mean dose of 370mCi. Post-thyroidectomy baseline thyroglobulin levels in this subgroup of patients were >10 µg/L in 6, >2 µg/L in 1, 0-2 µg/L in 2 and unknown in 1. Patients downgraded from stage IV/III to stage II had lymph node metastases (38%) or distant metastases (60%), received treatment with Tyrosine-Kinase Inhibitors (50%) and underwent more than 1 course of RAI (50%) during their disease.  

Conclusion In PD TC and WD TC patients downgraded from stage IV/III to stage II, the severity of disease should not be underestimated. A more accurate assessment of their mortality risk can be obtained by integrating TNM stage and post-thyroidectomy thyroglobulin levels.


Background According to the new 8th AJCC/TNM edition, we investigated the effect of downstaging in patients with thyroid cancer (TC).

Methods From a large cohort of patients actively followed-up for TC since 2002, we retrospectively reviewed 46 with disease-specific mortality (17 males, 29 females and mean age 67±13,96yrs). 

Results Histologically, TCs were: papillary (PTC) in 16 cases (35%), follicular in 8 (17%), both PTC and Hurthle cancer in 1 (2%), poorly differentiated (PD) in 6 (13%), anaplastic in 5 (11%) and medullary in 6 (13%). No histological diagnosis was available in 4. On diagnosis, 10 patients were aged <55yrs. In patients with PD TC and well-differentiated (WD) TC, disease-specific deaths occurred in 19. TNM stages were downgraded in 11 of these (58%): 6 patients from stage III to II; 3 patients from stage IV to III; and 2 patients from stage IV to II. Their mean age was 64yrs; 4 were aged <55yrs. Ten patients underwent radioactive iodine ablation (RAI) with a mean dose of 370mCi. Post-thyroidectomy baseline thyroglobulin levels in this subgroup of patients were >10 µg/L in 6, >2 µg/L in 1, 0-2 µg/L in 2 and unknown in 1. Patients downgraded from stage IV/III to stage II had lymph node metastases (38%) or distant metastases (60%), received treatment with Tyrosine-Kinase Inhibitors (50%) and underwent more than 1 course of RAI (50%) during their disease.  

Conclusion In PD TC and WD TC patients downgraded from stage IV/III to stage II, the severity of disease should not be underestimated. A more accurate assessment of their mortality risk can be obtained by integrating TNM stage and post-thyroidectomy thyroglobulin levels.


    This eLearning portal is powered by:
    This eLearning portal is powered by MULTIEPORTAL
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.


Save Settings